Accelerated approval was based on results from the Phase Ib Beamion-LUNG 1 trial (NCT04886804), which showed a 75% objective ...

Results from the Phase III NEPTUNUS-1 (NCT05350072) and NEPTUNUS-2 (NCT05349214) trials demonstrated that ianalumab ...

The journal is standing by the study, which looked into the safety of vaccines that have aluminum ingredients.

A new CDC campaign "Free Mind" addresses rising drug overdoses and mental health issues among youth, offering vital resources ...

Today, imaging often exists independently of molecular insights, trial data, treatment decisions, and longitudinal patient ...